Skip to content

Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic

Pilot Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03202420
Acronym
TOPS at DOC
Enrollment
26
Registered
2017-06-28
Start date
2017-12-22
Completion date
2019-12-05
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The purpose of this pilot proposal are the following: 1) to determine the feasibility and acceptability of integrating the TOPS weight loss program into underserved populations through an urban safety net clinic and 2) to gather preliminary data of weight change to inform the design of a future randomized, controlled trial to determine the efficacy of the TOPS program in safety net clinics. To achieve these goals, the investigators will pursue the following Specific Aims: Specific Aim 1. Assess the feasibility and acceptability of integrating the TOPS program into an urban safety net clinic, with process measures (i.e., recruitment/refusal rates and retention/dropout rates) and focus groups. Hypothesis 1. Integrating the TOPS program into an urban safety net clinic is feasible and acceptable to participants. Specific Aim 2. Assess the percent of participants in the TOPS intervention arm with clinically significant weight change (i.e., weight loss of ≥5% of initial body weight) at 12, 26, and 52 weeks. Hypothesis 2. 10%, 25%, and 33% of participants in the TOPS intervention arm will lose ≥5% of initial body weight at 12, 26, and 52 weeks, respectively.

Interventions

OTHERTOPS

Take Off Pounds Sensibly (TOPS) is a national, nonprofit, peer-led, group-based, weight loss program that offers a comprehensive program on diet and physical activity with group support for weight management.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants must be patients of the DOC. * BMI: Asian patients with a BMI of ≥23 kg/m2 and patients of other racial and ethnic backgrounds will be included if have a BMI of ≥25 kg/m2. Asian patients are allowed to participate at a BMI in the normal range because they are more likely to develop diabetes (or insulin resistance or glucose intolerance at a BMI of 23 kg/m2).

Exclusion criteria

* Mental illness that would cause disruptions to group meetings * Cognitive impairment that would preclude participants from understanding the program * Type 2 diabetics on insulin or sulfonylureas without provider approval * untreated hyper- or hypothyroidism * current cancer diagnosis * history of cancer (other than skin cancer) * gastrointestinal disorders affecting food intake * use of medications thought to effect metabolism, body weight, energy expenditure, or appetite * women currently pregnant or lactating, planning to become pregnant, or less than 6 months post-partum * weight loss of \> 5% in past 6 months * major psychiatric disorder * current moderate to severe symptoms of depression * eating disorders * current alcohol or substance abuse.

Design outcomes

Primary

MeasureTime frameDescription
Change in WeightBaseline, 12, 24, and 52 weeksWeekly weight data will be collected by the DOC Designee at baseline, 12, 24, and 52 weeks.

Secondary

MeasureTime frameDescription
Program Attendance52 WeeksCalculate the percentage of TOPS at DOC group session attendance (sessions attended/total offered).
Retention as measured by attendance sheets12, 24 and 52 weeksCalculate the retention of participants in the TOPS at DOC program at 12, 24, and 52 weeks.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026